74 related articles for article (PubMed ID: 19543207)
1. Role of endogenous ET-1 in the regulation of myocardial blood flow in lean and obese humans.
Mather KJ; Lteif AA; Veeneman E; Fain R; Giger S; Perry K; Hutchins GD
Obesity (Silver Spring); 2010 Jan; 18(1):63-70. PubMed ID: 19543207
[TBL] [Abstract][Full Text] [Related]
2. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.
Mather KJ; Lteif A; Steinberg HO; Baron AD
Diabetes; 2004 Aug; 53(8):2060-6. PubMed ID: 15277386
[TBL] [Abstract][Full Text] [Related]
3. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.
Mather KJ; Mirzamohammadi B; Lteif A; Steinberg HO; Baron AD
Diabetes; 2002 Dec; 51(12):3517-23. PubMed ID: 12453909
[TBL] [Abstract][Full Text] [Related]
4. Endothelin limits insulin action in obese/insulin-resistant humans.
Lteif A; Vaishnava P; Baron AD; Mather KJ
Diabetes; 2007 Mar; 56(3):728-34. PubMed ID: 17327443
[TBL] [Abstract][Full Text] [Related]
5. Endothelin contributes differently to peripheral vascular tone and blood pressure in human obesity and diabetes.
Yoon N; Lteif AA; Han K; Mather KJ
J Am Soc Hypertens; 2008; 2(3):182-91. PubMed ID: 20409901
[TBL] [Abstract][Full Text] [Related]
6. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients.
Cardillo C; Campia U; Iantorno M; Panza JA
Hypertension; 2004 Jan; 43(1):36-40. PubMed ID: 14656951
[TBL] [Abstract][Full Text] [Related]
7. The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone.
MacCarthy PA; Pegge NC; Prendergast BD; Shah AM; Groves PH
J Am Coll Cardiol; 2001 Jan; 37(1):137-43. PubMed ID: 11153728
[TBL] [Abstract][Full Text] [Related]
8. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects.
Polak K; Petternel V; Luksch A; Krohn J; Findl O; Polska E; Schmetterer L
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2949-56. PubMed ID: 11687541
[TBL] [Abstract][Full Text] [Related]
9. Insulin and endothelin in the acute regulation of adiponectin in vivo in humans.
Brame LA; Considine RV; Yamauchi M; Baron AD; Mather KJ
Obes Res; 2005 Mar; 13(3):582-8. PubMed ID: 15833944
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.
Lteif AA; Fulford AD; Considine RV; Gelfand I; Baron AD; Mather KJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1510-7. PubMed ID: 18957616
[TBL] [Abstract][Full Text] [Related]
11. Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension.
Bruno RM; Sudano I; Ghiadoni L; Masi L; Taddei S
Hypertension; 2011 Jan; 57(1):79-84. PubMed ID: 21059990
[TBL] [Abstract][Full Text] [Related]
12. Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease.
Ahlborg G; Shemyakin A; Böhm F; Gonon A; Pernow J
Diabetes Care; 2007 Mar; 30(3):591-6. PubMed ID: 17327326
[TBL] [Abstract][Full Text] [Related]
13. Obesity affects myocardial vasoreactivity and coronary flow response to insulin.
Sundell J; Laine H; Luotolahti M; Kalliokoski K; Raitakari O; Nuutila P; Knuuti J
Obes Res; 2002 Jul; 10(7):617-24. PubMed ID: 12105283
[TBL] [Abstract][Full Text] [Related]
14. Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus.
McAuley DF; Nugent AG; McGurk C; Maguire S; Hayes JR; Johnston GD
Clin Sci (Lond); 2000 Sep; 99(3):175-9. PubMed ID: 11787468
[TBL] [Abstract][Full Text] [Related]
15. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men.
Laine H; Nuutila P; Luotolahti M; Meyer C; Elomaa T; Koskinen P; Rönnemaa T; Knuuti J
J Clin Endocrinol Metab; 2000 May; 85(5):1868-73. PubMed ID: 10843167
[TBL] [Abstract][Full Text] [Related]
16. Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma.
Henry E; Newby DE; Webb DJ; Hadoke PW; O'Brien CJ
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2528-32. PubMed ID: 16723466
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-A receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy.
Settergren M; Pernow J; Brismar K; Jörneskog G; Kalani M
J Vasc Res; 2008; 45(4):295-302. PubMed ID: 18212505
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease.
Böhm F; Jensen J; Svane B; Settergren M; Pernow J
Can J Physiol Pharmacol; 2008 Nov; 86(11):745-51. PubMed ID: 19011669
[TBL] [Abstract][Full Text] [Related]
19. A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury.
Thijssen DH; Ellenkamp R; Kooijman M; Pickkers P; Rongen GA; Hopman MT; Smits P
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):325-31. PubMed ID: 17122448
[TBL] [Abstract][Full Text] [Related]
20. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
